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ABSTRACT
Objectives: To establish the attitudes of glaucoma
specialists to the frequency of visual field (VF) testing
in the UK, using the NICE recommendations as a
standard for ideal practice.
Design: Interview and postal survey.
Setting: UK and Eire Glaucoma Society national
meeting 2011 in Manchester, UK, with a second round
of surveys administered by post.
Participants: All consultant glaucoma specialists in
England and Wales were invited to complete the
survey.
Primary and secondary outcome measures:
(1) Compliance of assigned follow-up VF intervals with
NICE guidelines for three hypothetical patient
scenarios, with satisfactory treated intraocular pressure
and (a) no evidence of VF progression; (b) evidence of
VF progression and (c) uncertainty about VF
progression, and respondents were asked to provide
typical follow-up intervals representative of their
practice; (2) attitudes to research recommendations for
six VF in the first 2 years for newly diagnosed patients
with glaucoma.
Results: 70 glaucoma specialists completed the
survey. For each of the clinical scenarios a, b and c,
14 (20%), 33 (47%) and 28 (40%) responses,
respectively, fell outside the follow-up interval
recommended by NICE. Nearly half of the specialists
(46%) agreed that 6 VF tests in the first 2 years was
ideal practice, while 16 (28%) said this was practice
‘not possible’, with many giving resources within the
NHS setting as a limiting factor.
Conclusions: The results from this survey suggest
that there is a large variation in attitudes to follow-up
intervals for patients with glaucoma in the UK, with
assigned intervals for VF testing which are, in many
cases, inconsistent with the guidelines from NICE.
INTRODUCTION
Visual ﬁeld (VF) testing, in the form of
standard automated perimetry, is the most
frequently performed investigation for the
functional assessment of patients with
primary open-angle glaucoma (POAG) in
the UK.1 The aim of VF testing is to detect
functional deﬁcit in patients with suspected
disease and monitoring of patients with
established POAG.2
The frequency of VF tests over a given
period for a patient with POAG is governed
by the clinician’s estimate of the likelihood
and speed of progression of disease, which in
turn may depend on the level of intraocular
pressure (IOP) control and stage of disease
ARTICLE SUMMARY
Article focus
▪ There are approximately one million
glaucoma-related outpatient visits in the National
Health Service annually.
▪ Visual field (VF) testing is one of the most fre-
quent investigations performed for monitoring
patients with glaucoma and requires substantial
and specialist resource utilisation.
▪ A survey was conducted to establish attitudes to
the frequency of VF testing in the UK with refer-
ence to guidelines from the National Institute of
Clinical Excellence (NICE) and research
recommendations.
Key messages
▪ VF monitoring intervals assigned by clinicians
(for hypothetical patient scenarios) are very vari-
able and often outside intervals recommended
by NICE.
▪ Many specialists regard the research-recommended
routine performance of six VF examinations in the
first 2 years as impractical in the current health
setting.
Strengths and limitations of this study
▪ This is the first survey to establish the views of
glaucoma subspecialists to the VF monitoring
intervals for patients with glaucoma.
▪ The surveyed population accounted for approxi-
mately half of the specialists nationally and the
assumption has been made that this sample is
representative of UK practice.
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as well as other factors such as the age of the patient
and degree of VF reliability. Test intervals are essentially
a risk/beneﬁt trade-off: an interval which is too long
may allow timely detection of progressive VF loss to be
missed while multiple tests at short-test intervals in
patients at low risk of progression may mean unneces-
sary extra visits and use of hospital resource. Although
some published guidelines regarding the frequency of
VF testing are available, these vary considerably.3 4
Results from statistical modelling suggest that six VF tests
in 2 years (ie, approximately 1 every 4 months) in newly
diagnosed patients may be necessary to allow detection
of patients who may be progressing ‘rapidly’ in terms of
VF loss.5 The National Institute of Clinical Excellence
(NICE) has recognised the current lack of evidence
regarding the frequency of monitoring intervals for
patients with POAG and recommended future research
in this area of study to substantiate current practice.3
Indeed, recent research has focused on the optimum
number and interval between VF tests for patients.6
Given that POAG accounts for a major proportion of
ophthalmology workload, with an estimated one million
outpatient visits in the UK annually,3 the frequency of
testing has important implications for resource manage-
ment and service delivery, as well as cost in the out-
patient setting.
We undertook a national survey to establish the atti-
tudes of glaucoma subspecialists to the frequency of VF
testing, using NICE recommendations as a benchmark,
and also sought to investigate perceived barriers to fre-
quent VF testing of patients with glaucoma.
MATERIALS AND METHODS
The current study was undertaken as part of a larger
National Institute for Health Research (NIHR)-funded
project to evaluate factors governing VF test intervals in
clinical practice. The current study was needed in order
to infer the extent to which actual VF intervals and fre-
quency (investigated in a national audit of practice) may
be inﬂuenced by the attitude of clinicians.
Survey population
The questionnaire was administered to all UK glaucoma
consultants by two methods to ensure maximum
response: (1) by hand at the UK & Eire Glaucoma
Society (UKEGS) Meeting in December 2011 in
Manchester or (2) by post, with a self-addressed prepaid
envelope, in February 2012. All responses were carried
out by self-completion of the questionnaire and were
collected anonymously and then combined to form one
dataset. All glaucoma specialists, identiﬁed from a list
provided by the Royal College of Ophthalmologists
(n=150), were sent the postal survey. Specialists who had
previously completed the survey at UKEGS were
requested not to respond again. This study was reviewed
and approved by the City University London School of
Health Science Research and Ethics committee.
Questionnaire design
The questionnaire consisted of ﬁve questions. Questions
1–3 were used to gather information of the grade and
location of work (England and Wales) of the responders
and to identify consultants with a subspecialist interest in
glaucoma. Question 4 described three distinct situations
designed to simulate common clinical scenarios. For
patients with POAG who were being monitored on treat-
ment and attending a follow-up assessment, responders
were asked to assign typical follow-up assessment intervals
for a patient with IOP deemed to be at (or below) ‘target
IOP’ and
a. No evidence of VF progression and no change in
treatment
b. Evidence of VF progression and change of treatment
c. Uncertainty about VF progression and no change of
treatment
These scenarios were chosen to reﬂect the clinical situa-
tions which have been given by NICE.3 Follow-up intervals
of 6–12 months for the ﬁrst scenario and 2–6 months for
the latter two have been recommended by NICE.
The last question, question 5, was open ended; specia-
lists were asked their views about research that has sug-
gested that all newly diagnosed patients would beneﬁt
from six VF examinations (every 4 months) in the ﬁrst
2 years of follow-up from diagnosis in order to identify
rapidly progressing patients.5
Data analysis
For each of the patient scenarios in question 4, the
follow-up interval given by each responder was com-
pared with NICE-recommended intervals. The propor-
tion of responses (with either the minimum or
maximum interval) lying outside NICE-recommended
intervals was computed (ﬁgure 1).
For question 5 (whether 6 VFs should be performed in
the ﬁrst 2 years for newly diagnosed patients), responses
were classiﬁed into ﬁve categories for ease of reporting:
‘agree’; ‘diasgree’, already represents ‘current practice’
locally; ‘not possible’ and possible ‘alternatives’ to this
practice and are represented in a pie chart (ﬁgure 2).
RESULTS
The questionnaire was returned by 70 Consultant
Ophthalmologists currently employed in England and
Wales and with a self-declared specialist interest in glau-
coma. From the conference, responses were obtained from
28 specialists. The remainder of the responses (42) were
received through the postal survey. Figure 1 shows the
follow-up intervals given by each of the responders for each
of the clinical scenarios a, b and c described in question
4. For each of these, 14 (20%), 33 (47%) and 28 (40%)
responses, respectively, fell outside the follow-up interval
recommended by NICE. (The width of the 95% CI asso-
ciated with these estimates, with n=70, is about ±12%.)
Question 5 was answered by 57 of the 70 specialists.
Nearly half of these (26/57=46%) agreed that six VF
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tests in the ﬁrst 2 years was ideal practice (ﬁgure 2), but
admitted that the practicalities of this would be challen-
ging. Example responses that fell in this category
included, “Agree but practical issues found in a busy
glaucoma clinic may be a hurdle to achieve this target.”
Two delegates (3%) indicated that this was already
their current practice. Six specialists (11%) disagreed
with the suggestion of six VF tests, while 16 (28%) said
this was ‘not possible’, again listing limited ‘capacity’ or
resources as a constraining factor. (The width of the
95% CI associated with these estimates, with n=57, is
about ±15%.) Examples of responses that fell in the
latter category included, “Totally out of touch with what
is possible in the current NHS clinics with such limited
capacity.” A few alternatives were suggested to the six VF
tests, including alternating imaging and VF tests for
detecting progression. For example, one responder
stated, “Instead of function tests, structural ones: GDx
(scanning laser polarimetry)/OCT would be better.”
DISCUSSION
The aim of the present study was to report the attitudes
of glaucoma consultant subspecialists in England and
Figure 1 Responses from 70
Consultant Ophthalmologists with
a declared subspecialist interest
in glaucoma, giving minimum
(lower error bars) and maximum
(upper error bars) follow-up
intervals for a hypothetical patient
with intraocular pressure at
‘target’ and (A) no evidence of
visual field progression and no
change in treatment; (B) evidence
of visual field progression and no
change in treatment; (C)
uncertainty about visual field
progression and no change in
treatment. Single bars represent
values for which only a single
interval was given by
respondents, without specifying
the minimum / maximum
monitoring interval.
Figure 2 Summary of views of responders to the suggestion
that six visual field tests should be performed in the first 2
years for a newly diagnosed patient with primary open-angle
glaucoma.
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Wales to the frequency of VF testing for patients with
glaucoma, by exploring the designated test intervals for
patients in three clinical scenarios. The hypothesis was
that clinicians would be fully compliant with NICE
guidelines in their attitudes to intervals for VF testing.
However, the results of the survey disprove this hypoth-
esis. We found a wide variation in the designated test
intervals, with respect to NICE recommendations. This
variation in attitudes is likely to reﬂect differences in
clinical practice, although this has yet to be established.
A recent retrospective study of 100 patients conducted at
a single centre found that 89% of assigned monitoring
intervals were in accordance with NICE guidelines.7
The variation in individual attitudes to the frequency
of testing is reﬂected in differing recommendations for
the frequency of testing in glaucoma. For example,
NICE recommend VF testing at 6–12 month intervals for
a patient at target IOP and a stable VF.3 The European
Glaucoma Society (EGS) recommends three VF tests in
the ﬁrst 2 years for a newly diagnosed patient with glau-
coma, with less speciﬁc guidance thereafter.4
Given that more frequent testing is associated with a
higher likelihood of identifying progression, variations
in practice with regard to the frequency of testing are
likely to imply inconsistencies in patient management
and resource utilisation nationally. The authors estimate
the cost of a single VF in an NHS setting to be in excess
of 50 pounds per test.8 There are approximately 10 000
new cases of POAG per year. With these estimated costs,
three tests per year equate to a cost of 1.5 million
pounds per year for this newly diagnosed patient cohort
alone. Clearly, the outpatient workload for patients with
glaucoma has substantial cost implications for the NHS.
In view of the implications of frequent testing, it is
unsurprising that research has focused on the frequency
and intervals of VF tests.5 6 9–12 One suggested approach
is to vary the inter-test interval based on the outcome of
previous tests.11 12 Most of this research has recom-
mended increasing the frequency of VF testing to
ensure better sensitivity in diagnosing progression,
without perhaps considering the cost/beneﬁt ratio, or
problems with false-positive detection in the presence of
increased testing. One recent study proposed multiple
tests at the start and end of a ﬁxed ‘observation’ period,
for more reliable identiﬁcation of progressing patients.6
It is interesting that three VF tests annually, the
number which may be required to detect ‘rapidly’ pro-
gressing patients and is consistent with the number
recommended by NICE for patients with suboptimal
IOP and evidence of progression, was seen as impractical
by many UK ophthalmologists with a specialist interest
in glaucoma in terms of availability of hospital resources.
It would seem that the potential utility of UK ophthal-
mology departments to perform the number of VFs to
meet clinical guidelines needs further investigation.
While outsourcing visits to a community setting may
lighten the hospital burden, this may have overall
adverse cost implications.13 A further discussion of issues
about service delivery for glaucoma management is
beyond the scope of this report. One possible approach
to increasing diagnostic power to detect progression in
the face of a limited number of VF tests is to use alterna-
tive technology, in addition to VF testing for monitoring,
such as optic nerve head imaging. Several methods have
recently been suggested for integrating structural and
functional tests for glaucoma progression,14–16 and the
use of an additional diagnostic modality leads to greater
accuracy for detecting progression than VF tests alone.15
It remains to be seen if these research ideas can trans-
late to clinical practice.
A limitation of this and all studies of this nature is the
response rate. An assumption has been made that
responses from the surveyed consultants are representa-
tive of subspecialist national practice in England and
Wales. There are approximately 150 Consultant
Ophthalmologists in England and Wales with a glau-
coma subspecialist interest as estimated from a list
obtained from the Royal College of Ophthalmologists.
Our surveyed population would therefore represent
nearly half of the glaucoma specialists nationally.
Further, an assumption has been made that the method
of survey delivery (conference or postal) has not inﬂu-
enced responses from participants and that the
responses have been combined for reporting.
Responses to question 5 were classiﬁed into distinct
categories, for ease of interpretation, by only one of the
investigators (HB). As the responses were generally non-
ambiguous, it is unlikely that subjectivity contributed to
the misclassiﬁcation of responses. The survey used was
developed by consensus between scientists in vision
research, psychology and ophthalmologists and is not a
validated tool for assessing attitudes for VF testing.
In conclusion, the variable attitudes of ophthalmolo-
gists with a glaucoma subspecialty to the frequency of VF
testing in England and Wales highlight the need for
further research in this area to ﬁrst establish current
practice and, second, to provide a ﬁrmer evidence base
for designated VF test intervals. The longer term goal
would be to ensure optimal resource utilisation and a
consistent, high standard of practice nationally.
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